Licart: payments to doctors
Payments that named Licart as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $848K
- Providers
- 14,871
- Transactions
- 39,572
- Average per transaction
- $21
The per-transaction average — $21 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 14,871 providers the average total is $57, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| IBSA Pharma Inc. | $842,737 | 99.3% |
| IBSA Institut Biochimique SA | $5,700 | 0.7% |